Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell of artery | 11 studies | 35% ± 13% | |
endothelial cell | 7 studies | 21% ± 5% | |
glomerular endothelial cell | 3 studies | 24% ± 4% |
Insufficient scRNA-seq data for expression of SEMA3G at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 13792.40 | 458 / 459 | 96% | 17.83 | 1072 / 1118 |
thymus | 95% | 1788.31 | 621 / 653 | 98% | 13.35 | 592 / 605 |
kidney | 100% | 3826.15 | 89 / 89 | 85% | 13.95 | 768 / 901 |
lung | 98% | 5206.02 | 567 / 578 | 82% | 4.99 | 950 / 1155 |
brain | 84% | 1923.88 | 2217 / 2642 | 90% | 9.62 | 635 / 705 |
prostate | 69% | 948.07 | 169 / 245 | 97% | 8.09 | 485 / 502 |
bladder | 90% | 1741.00 | 19 / 21 | 70% | 4.06 | 352 / 504 |
esophagus | 76% | 1356.05 | 1099 / 1445 | 72% | 3.97 | 131 / 183 |
intestine | 81% | 1415.63 | 784 / 966 | 64% | 3.87 | 338 / 527 |
uterus | 84% | 1231.98 | 143 / 170 | 60% | 3.99 | 276 / 459 |
stomach | 67% | 840.09 | 239 / 359 | 73% | 5.00 | 209 / 286 |
skin | 68% | 1731.80 | 1238 / 1809 | 70% | 5.08 | 329 / 472 |
pancreas | 9% | 80.74 | 30 / 328 | 94% | 9.34 | 167 / 178 |
adrenal gland | 14% | 143.03 | 36 / 258 | 87% | 16.51 | 200 / 230 |
adipose | 100% | 14918.68 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 99% | 1638.76 | 238 / 241 | 0% | 0 | 0 / 0 |
heart | 95% | 1799.38 | 821 / 861 | 0% | 0 | 0 / 0 |
ovary | 36% | 497.67 | 64 / 180 | 54% | 2.56 | 231 / 430 |
muscle | 82% | 1189.72 | 660 / 803 | 0% | 0 | 0 / 0 |
liver | 2% | 13.62 | 4 / 226 | 79% | 5.72 | 322 / 406 |
tonsil | 0% | 0 | 0 / 0 | 78% | 4.56 | 35 / 45 |
blood vessel | 48% | 852.59 | 647 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 48% | 1.62 | 14 / 29 |
eye | 0% | 0 | 0 / 0 | 24% | 0.78 | 19 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030517 | Biological process | negative regulation of axon extension |
GO_0071526 | Biological process | semaphorin-plexin signaling pathway |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0001755 | Biological process | neural crest cell migration |
GO_0007411 | Biological process | axon guidance |
GO_0050919 | Biological process | negative chemotaxis |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0045499 | Molecular function | chemorepellent activity |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0030215 | Molecular function | semaphorin receptor binding |
Gene name | SEMA3G |
Protein name | Semaphorin 3G Semaphorin-3G (Semaphorin sem2) |
Synonyms | |
Description | FUNCTION: Has chemorepulsive activities for sympathetic axons. Ligand of NRP2 (By similarity). . |
Accessions | ENST00000231721.7 ENST00000465657.1 ENST00000475739.1 H7C5M7 C9JXB2 Q9NS98 |